Access to anti-retroviral drugs, female in Eswatini
Eswatini: Access to anti-retroviral drugs, female was 98.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in Eswatini, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
In 2024, access to anti-retroviral drugs, female in Eswatini stood at 98.0%. That is the highest value across all 25 years on record.
The figure is up 71.9% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Eswatini peaked at 98.0% in 2020 and was at its lowest, 0.0%, in 2000.
That places Eswatini 1st out of 141 countries with data for 2024, putting it in the top 10%.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in Eswatini, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 1.0% | — |
| 2003 | 1.0% | +0.0% |
| 2004 | 3.0% | +200.0% |
| 2005 | 5.0% | +66.7% |
| 2006 | 9.0% | +80.0% |
| 2007 | 15.0% | +66.7% |
| 2008 | 19.0% | +26.7% |
| 2009 | 24.0% | +26.3% |
| 2010 | 34.0% | +41.7% |
| 2011 | 37.0% | +8.8% |
| 2012 | 41.0% | +10.8% |
| 2013 | 46.0% | +12.2% |
| 2014 | 57.0% | +23.9% |
| 2015 | 75.0% | +31.6% |
| 2016 | 87.0% | +16.0% |
| 2017 | 87.0% | +0.0% |
| 2018 | 87.0% | +0.0% |
| 2019 | 93.0% | +6.9% |
| 2020 | 98.0% | +5.4% |
| 2021 | 96.0% | -2.0% |
| 2022 | 97.0% | +1.0% |
| 2023 | 98.0% | +1.0% |
| 2024 | 98.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 7.7% | 0.0% | 24.0% | 10 |
| 2010s | 64.4% | 34.0% | 93.0% | 10 |
| 2020s | 97.4% | 96.0% | 98.0% | 5 |
Countries ranked near Eswatini
More gender data for Eswatini
- Child population (UN estimates and projections) 409.82 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -0.2852 % change on previous year (2030)
- Population 911.1 (2030)
- Working-age population (UN estimates and projections) 911.1 (2030)
- Population (UN estimates and projections), annual growth rate 1.53 % change on previous year (2030)
- Age population, age 00, female, interpolated 13,962 (2025)
- Age population, age 00, male, interpolated 14,289 (2025)
- Age population, age 01, female, interpolated 13,860 (2025)
- Age population, age 01, male, interpolated 14,185 (2025)
- Age population, age 02, female, interpolated 13,878 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Eswatini?
- Access to anti-retroviral drugs, female in Eswatini was 98.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Eswatini?
- The highest recorded value was 98.0% in 2020.
- What is the lowest access to anti-retroviral drugs, female recorded in Eswatini?
- The lowest recorded value was 0.0% in 2000.
- How does Eswatini rank for access to anti-retroviral drugs, female?
- Eswatini ranks 1st out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Eswatini?
- Over the last ten years it is up 71.9%. The long-run trend across the full record is volatile.
- Where does this Eswatini data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.